Gout market across 7MM set to reach $10.8 bn in 2032 fueled by novel ULTs and rising prevalence:… EP News Bureau Jan 11, 2024 There are nine therapies in the late-stage pipeline, most of which are urate-lowering therapies (ULTs) entering the US and Japan…
